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INTRODUCTION 
Bone neoplasms  has been routinely treated by either chemotherapy or 
radiotherapy/surgery. Current practice, in treatment of benign neoplasms like 
osteoid osteoma is inclining towards minimally invasive procedures like 
chemo or thermo ablation (1). 
In ablative procedures, neoplastic cells are cooked to temperatures 
more than 60℃ and destroyed completely. This can be achieved by 
radiofrequency (RF) energy, microwaves or laser therapy. Cryotherapy is also 
a form of ablation technique in which neoplastic cells are destroyed by 
freezing to temperature less than - 20℃(1). MR guided focused ultrasound is 
an advanced non- invasive radiation free modality, sharp focus of ultrasound 
waves targeted towards lesions eventually leads to thermo-ablation (> 57℃). 
Image guided radio frequency ablation (RFA) is leading among all 
minimally invasive procedures in Skeletal oncology. Because, it’s a safe, cost 
effective & less morbid treatment tool for bone lesions. It is relatively newer 
technique with better success.         
Success of procedure usually depends upon image guidance. CT leads 
over other imaging modalities like ultrasound or  magnetic resonance imaging 
in guidance. Because, images are acquired faster with better bone resolution 
(1). 
Radiofrequency ablation is a recently developed treatment modality in 
which neoplasms in liver, lung & bone can be effectively treated with less 
morbidity (2). 
Benign bone tumours like osteoid osteoma and osteoblastoma can be 
completely cured using RFA. It is also effective in alleviating   pain in malignant 
lesions like metastasis (2). 
Osteoid osteoma is an extremely painful benign bone lesion typically 
smaller than 1.5cm (2), with pain getting worsened in night and relieved by 
salicylates which has predilection for young boys. Image guided 
radiofrequency ablation is the current treatment modality of choice in treating 
osteoid osteoma with 95 to 100% cure rate (1,2). 
Our study is focused in evaluating the technical and therapeutic 
efficacy of radiofrequency ablation of osteoid osteoma at our institution, to 
assess the technical limitations and post procedural complications.  
  
 AIM 
To evaluate the therapeutic efficacy of   Image  Guided Radio frequency 
ablation in benign bone tumour osteoid osteoma. 
OBJECTIVES: 
The objectives of this study were, 
1. To assess the technical success in radiofrequency ablation procedure. 
2. To compare the   Pre- operative visual analog score with Post 
procedure visual analog score at one week and four weeks and, 
assessing the clinical success rate. 
3. To correlate the nidus size and histopathological report. 
4. To compare pre-operative imaging with post procedure follow up 
imaging at 4 weeks. 
  
REVIEW OF LITERATURE 
OSTEOID OSTEOMA: 
Jaffe in the year 1935 (3,12) described “core” or “nidus like focus” this 
later termed as “nidus” refers to tumour itself which has various stages of 
bone maturity in a rich vascularized connective tissue (4,13). 
Nidus center as the highest mineralization with varying amounts of 
mineralization (Figure1). 
                   
  
 
  
Figure 1 - Specimen radiograph (4): Calcified round nidus separated from normal 
bone. 
 
CLINICAL PRESENTATION: 
10 -12% of benign bone tumours   and 2 to 3% primary bone tumours 
are osteoid osteomas with peak age at 2nd decade (3,14) (Figure 2). Male to 
female ranges from 1.6:1 to 4:1(3,14). 
 
 
 
Patients invariably presents with deep, aching, and intense pain last for 
weeks or months before diagnosis, which worsens at night and pain relieved 
by taking aspirin (3). 
Clinical course varies depending upon location like intra articular 
lesions with synovitis & joint restriction & spinal lesions with painful 
scoliosis(3). 
  
Figure 2: Distribution based on age decade of osteoid osteoma 
presentation (5). 
SKELETAL DISTRIBUTION: 
Can arise anywhere in appendicular/axial skeleton. Most common 
location was lower extremities either femoral or tibial (Figure 3) diaphysis / 
Metadiaphysis region (3,14). 
 
 
Lesions distribution can be cortical, medullary & sub-periosteal (Figure 
4). Among them cortical lesions are more common and medullary/ sub-
periosteal lesions are uncommon and noted in intraarticular or juxta-articular 
location (3,14).                                            
  
 
Figure 3: Anatomical Sites of Origin (5). 
  
 
HISTOPATHOLOGY AND PATHOGENESIS: 
These osteoblastic tumours measures   1.5–2 cm in diameter and rarely 
exceeds. The nidus, contains interconnected trabeculae of osteoid/woven 
bone. Osteoblasts and variable amount of osteoclasts are surrounded by loose 
fibrovascular connective tissue (3,13) (figure 5). 
Central nidus has abundant mineralization, going for the calcification 
within the lucent area. Perilesional sclerosis is not a part of the tumour.  
Though sclerosis is reversible, it is due to the pressure exerted by richly 
vascularized lesion within the host bone. Bone marrow elements, cartilage & 
mitotic figures are generally not seen.(3,13,15). 
Exact pathogenesis of osteoid osteoma remains unclear. Mungo et al., 
study in 2002 reveals raised levels of COX – 2 in nidus and also shows, high 
Figure 4: Distribution of Disease According to the Site of Origin (5). 
levels of PGE2 & prostacyclin, leading to local inflammation and vasodilation. 
In addition, high concentrations of unmyelinated nerve fibers within nidus 
causes excruciating pain. (3,16) 
Thus, COX-2 inhibition has become a theorized mechanism by which 
aspirin (NSAIDs) provide symptomatic relief for osteoid osteomas(3,16). 
 
 
 
 
  
Figure 5: Osteoid osteoma – Interlacing trabeculae of woven bone and 
osteoid(arrows) with osteoblastic rimming. Highly vascularized intervening 
stroma. 
IMAGING: 
RADIOGRAPH: 
The nidus is either oval or round shaped with size smaller than 2 cm, i.e 
radiolucent focus is seen in the center of reactive sclerosis. The nidus shows a 
varying amounts of calcification(mineralization), with adjacent cortical 
thickening, usually seen in diaphysis of long bones (4) (figure 6). 
Epimetaphyseal lesions may show minimal sclerosis surrounding the nidus. 
Medullary lesions, produce mild-to-moderate eccentric sclerosis (3). 
Decreased bone density because of disuse due to pain (4,17). 
 
 
 
 
Figure 6: Lateral radiograph shows oval lucent nidus (arrow) within tibial 
cortex with perinidal sclerosis (3). 
CT: 
Diagnostic modality of choice for tumor identification and 
characterization. Thin-section CT (1–2-mm slices) reconstructed in bone 
algorithm with multiplanar reformats is ideal (3,14). Usually, the nidus is well 
demarcated with less density (4) (figure7). Nidus mineralization, may be 
amorphous /punctate or ringlike (3,14) (figure 8). Reactive perinidal sclerosis 
will be seen varying from mild - severe in which, it may completely obscures 
the nidus (4,17.) 
 
               
 
 
 
Figure 7: Axial plain CT shows central calcification within nidus (arrow) in tibial 
cortex, with sclerosis in anterior tibial medullary cavity (3). 
  
 
The amount of perinidal, inflammation for lesions within or around the 
joint is variable, ranges from mild sclerosis to florid marrow signal changes 
and periarticular edema. (3) (figure 9). 
                         
 
 
Figure 8: AP radiograph and coronal CT shows lucent nidus (arrows), with 
ringlike, calcifications noted on inner aspect of femoral cortex (3). 
Figure 9: Coronal plain CT knee - Nidus (arrow) with relatively mild degree of 
perinidal sclerosis in subarticular position within lateral tibial plateau (3). 
 
  
Spinal osteoid osteomas are better characterized by CT. lesions 
typically presents as low attenuation nidus in posterior elements. Ipsilateral 
pedicle/lamina/transverse process may show reactive sclerosis. Ipsilateral 
scoliosis concavity also seen (3,19)(figure 10). 
 
 
 
 
  
Figure 10: Spinal osteoid osteoma - AP radiograph of lumbar spine reveals left 
convex scoliosis and subtle sclerosis (arrow) involving right aspect of L4 
vertebral body. Axial plain CT, shows hypodense nidus (arrow) with mild 
lesional sclerosis in Lumbar right inferior facet (3). 
Dynamic CECT: 
Tumor nidus shows rapid early arterial enhancement (25 - 30 s), 
classically more than 40 HU above the unenhanced CT with persistent venous 
phase enhancement (90 -120s), with gradual washout of contrast and return 
to unenhanced CT attenuation (3,20,21). 
Perilesional arteries enhancement parallels the lesion enhancement 
both in degree & timing of enhancement. This enhancement pattern helps to 
differentiate osteoid osteoma from its mimics like bone cysts & brodie’s 
abscess because, both are avascular (3,20,21). 
BONE SCINTIGRAPHY: 
Technetium-99–labeled bone scan helpful for confirming the diagnosis 
of osteoid osteoma with sensitivity of nearly 100% (3,22). “Double-density 
sign” is the classic scintigraphic finding on bone scan with high specificity, 
particularly in appendicular skeleton (3,23). The nidus shows central focus of 
very high bone turnover. Peri nidal portion shows less-intense radiotracer 
uptake, representing immune response (3,23) (figure 11). 
 
 
 
  
 
 
 
 
 
 In 1987 study by Helms et  al., all patients who are histologically proven 
osteoid osteoma exhibited this scintigraphic appearance. The sign is less 
specific with spinal lesions, because of the less sclerosis in the vertebrae (3,23) 
(figure 12). 
 
 
 
Figure 11: Coronal CT image – oval shaped nidus (arrow) with central 
calcification in radial diaphysis with surrounding sclerosis. Technetium-99 
bone scintigraphy shows double-density sign (3). 
 
  
 
 
 
 
 
 
 
Regarding imaging technique, the double-density pattern is better 
picked up by pinhole magnification scintigraphy compared to high-resolution 
planar scintigraphy. Imperiale et al., stated that the tumor nidus shows 18F-
FDG avidity, whereas the surrounding sclerosis does not (3,24). 
Figure 12: Osteoid osteoma -  C4 left pars interarticularis. CT cervical spine 
shows oval lytic mildly expansile lesion (arrow) with central calcification in left 
posterior elements with mild sclerosis of adjacent facet. Left lateral view of 
cervical spine bone scan shows focal (arrow) radiotracer uptake, corresponding 
to tumor nidus.no double density sign (3). 
PET will be helpful in both diagnostic and post treatment assessment. 
Because,4 weeks after Radiofrequency Ablation, the nidus was no longer 
hypermetabolic (3). 
  
MRI: 
Nidus appearance varies in MRI. The nidus shows low to- intermediate 
T1-weighted signal and heterogeneously high signal on T2-weighted/STIR 
sequences. On both T1- and T2-weighted sequences nidus central calcification 
appears as hypointense (3,15,25,26) (figure 13). 
On both T1- and T2-weighted sequences, peri nidal sclerosis appears as 
fusiform hypointensity. MRI also shows edema in adjacent bone marrow as 
well as surrounding soft tissues (3,25,26). 
Nidus enhancement pattern is variable; most of them enhance diffusely 
as a result of their intrinsic vascularity. however, few of them may show 
heterogeneous rim enhancement (3,25) (figure 14). 
A study by Assoun et al., concluded that thin slice CT was more 
accurate than MRI in detecting tumor nidus in 2/3rd  of cases (3,26). 
 
 
 
 
 
 
  
 
 
 
 
 
A study by Davies et al., reported that using MRI alone as imaging 
modality missed 1/3rd (15/43) of osteoid osteoma cases. The 15 cases included 
6 lesions were not identified at all and 9 lesions were poorly visualized. Small 
lesions difficult to identify on MRI because the nidus signal as similar intensity 
to that of the surrounding cortex (3,25).      
 
 
Figure 13: Femoral osteoid osteoma – Pre contrast T1-weighted image reveals 
hypointense nidus (large arrow) with fusiform cortical thickening (small 
arrows) overlying nidus. Post contrast T1-weighted image shows 
homogeneous nidus enhancement (arrow) (3). 
  
 
                                 
 
 
 
 
  
Figure 14: Tibial Intracortical osteoid osteoma - (a) CT shows nidus (arrow) with 
central calcification and adjacent sclerosis (*) (b) Axial T2W MR reveals heterointense 
nidus. (c, d) Axial plain and Post contrast T1W MR reveals low-signal intense nidus 
with strong enhancement, with adjacent edema (*) (4). 
 INTRA-ARTICULAR OSTEOID OSTEOMA: 
Rare, clinical variety in which lesion seen within or near a joint. Joint 
tenderness and joint effusion are the common symptoms. Hip is the most 
commonly involved joint (4,27). 
Imaging findings varies in intraarticular osteoid osteoma, there is 
minimal or absent reactive cortical thickening (figure 15), and it is believed to 
be due to absence of the innermost periosteal layer i.e cambium (4,27). 
However, newer studies have shown that the femoral neck periosteum has 
osteogenic potential (4,28). 
 
 
 
 
 
  
Figure 15: Intraarticular osteoid osteoma femur. Coronal T2WI MR showing a 
mineralised nidus (arrow) in neck with adjacent marrow edema (*). Large joint 
effusion is noted. Sagittal post contrast T1WI image shows mineralized nidus 
and marked synovial enhancement (4). 
 OSTEOBLASTOMA: 
Similar to osteoid osteoma in both histologically and clinically. but, 
Osteoblastoma is less aching than osteoid osteoma and won’t respond to aspirin 
(4). Moreover, osteoblastoma has progressive growth and may turn into 
malignant (4). At imaging, osteoblastoma measures larger than 2 cm, more 
expansile with less reactive sclerosis (4,36) (Fig 16). 
 
 
 
 
 
  
Figure 16. Osteoblastoma in humerus proximal diaphysis. AP radiograph 
showing well defined, expansile lytic cortical lesion (arrow) with sclerosis in 
proximal humeral diaphysis. Axial plain CT image reveals identical findings. 
Axial T2W MRI depicts the high intense lobulated lesion (arrow) (4). 
 
 
 
 
 
 
  
UNCOMMON LOCATIONS OF OSTEOID OSTEOMA: 
Less common locations are spine, hands, or feet. The least common 
sites are the skull, mandible, scapula, ribs(figure 17),and patella(4).  
A reactive inflammation which begins within hand spreads to nearby 
bones and joints. Lesions in hands and feet will have prominent swelling which 
mimics infection or inflammatory arthritis (4,13). 
 
 
 
 
  
Figure 17: Osteoid osteoma in posterior rib. AP radiograph reveals a nidus in rib 
with central calcification and mild sclerosis. CT axial plain image depicts nidal 
calcification (arrow) in rib’s anterior cortex(4). 
OSTEOID OSTEOMA MIMICS: 
Diagnostic dilemma of osteoid osteoma arises when certain conditions 
like chondroblastoma, stress fracture, Intra - cortical abscess / hemangioma 
and compensatory hypertrophy of the pedicle (4). 
Stress Fracture: 
Fracture occurring when stress on a bone overtakes the capacity of the 
bone to repair by its own. Common sites: the femoral neck and diaphysis of 
lower extremity bones (4,29). 
Imaging:  
1. Osteoid osteoma shows a round nidus. But, stress fracture shows 
central linear infarcted area within the thickened cortex (4,30)(figure 
18). 
2. Stress fracture, shows cortical thickening ranging from a linear cortical 
ridge to florid thickening in both aspects i.e periosteal and endosteal. 
whereas in osteoid osteoma, no linear cortical ridges are seen with 
varying cortical thickening (4,30). 
3. On scintigraphy, osteoid osteoma shows typical “double-density” sign. 
whereas, in stress fracture  marked linear  uptake can be seen (4,30). 
4.  In follow-up images, Cortical lesions size decreases in stress fracture 
rather than in osteoid osteoma(4,30). 
  
 
 
 
 
 
 
 
  
Figure 18: Tibial stress fracture -  Lateral radiograph of the left leg reveals mild 
tibial bowing, with adjacent cortical thickening, and raindrop like a radiolucent   
lesion (arrow) with tiny central calcification. Sag T1WI MR shows the 
hypointense lesion (arrow)with thickened cortex. Axial T2WI MR reveals the 
irregular shape of the lesion (4). 
Intracortical Abscess: 
In plain radiograph, a typical osteoid osteoma cannot be differentiated 
from an intracortical abscess with sequestrum (4,31). 
In CT, osteoid osteoma very well differentiated from an intracortical 
abscess. osteoid osteoma shows smooth nidal inner margin, with a central 
round mineralization. whereas, an intracortical abscess reveals inner irregular 
margin with eccentric irregularly shaped sequestrum (4,32) (Fig 19).             
In MRI, Intracortical abscess appears as hypointense on T1 and 
hyperintense on T2, with no central enhancement on contrast. But, in osteoid 
osteoma there will be avid nidal enhancement (4,33). 
 
 
 
 
Figure 19: Intracortical abscess of the femoral shaft. CT showing a lytic lesion 
with an irregular margins and eccentric sequestrum (arrow). Axial T2WI MR 
image showing hyperintense lesion with adjacent periosteal reaction(arrow 
heads) (4). 
 
 
 
 Intracortical hemangioma: 
Rarest tumor with tibial predominance.  Radiograph reveals a 
radiolucent intracortical lesion with horizontally oriented trabecular 
intralesional calcifications with cortical thickening/periostitis(4).  
CT shows a hypodense  lesion which is intracortical with net like 
internal calcification, i.e “wire-netting appearance”(4,34). 
MRI shows a high intense lesion with  low intense septa  and thickened 
cortex(4)(figure 20). 
 
 
 
 
  
Figure 20. Intracortical hemangioma of the tibia - Axial T2WI/Post contrast 
T1WI MR images revealing diffuse cortical thickening (arrowheads) with 
intracortical small lesion (arrow) and adjacent soft-tissue edema(4). 
 
 
 
 Chondroblastoma: 
Benign tumour with young age predilection & common in femur, 
humerus, and tibial epiphysis. Aggressive lesions with  significant periosteal 
reaction and large bone marrow edema. Small lesions are indistinguishable 
from subarticular osteoid osteoma. Chondroblastoma shows typical punctate 
mineralization, whereas osteoid osteoma shows central mineralization (4,35) 
(Fig 21). 
  
 
 
 
 
  
Figure 21. Chondroblastoma of the left medial femoral condyle – Axial plain CT 
shows an eccentrically placed epiphyseal lucent lesion (arrow) with expanded 
cortex. Axial T1W MR image reveals the low intense lesion (arrow) with adjacent 
bone marrow edema (*) (4). 
 
TREATMENT: 
Generally three approaches are used in treatment of osteoid osteomas: 
medical, surgical and percutaneous management(3,38).   
i) Conservative management: 
Treated with NSAID’s initially, and studies have found NSAID’S to be 
first choice medications with respect to long-term symptomatic relief. Goto et 
al., supported this in his study, 92% (11/12) of patients with osteoid osteoma 
treated with NSAIDs got pain relief at a mean interval of one and half years 
after treatment initiation (39). Several studies states that, the natural course 
of these lesions is spontaneous regression and NSAID’s accenuates this 
process (3,39). 
In 2002, a study by Mungo et al., Proposed that the  mechanism behind 
is central osteoblastic nidus has overexpression of cyclooxygenase-2. Another 
study reveals that, there is high levels of prostaglandin E2 and 
prostacyclin,thereby causing local vasodilatation and inflammation leading to 
pain(3,16). 
NSAID’s being nonselective inhibitors of the enzyme cyclooxygenase, 
blocks production of the cyclooxygenase-1 and -2 isoenzymes. thereby, 
cyclooxygenase-2 blockage has become a theorized mechanism by which 
these drugs provide symptomatic relief for osteoid osteomas (3,16). 
 However, patients getting long-term NSAID’s therapy, won’t tolerate 
drugs because of its side effects on GI tract and pain recurs, once these drugs 
are discontinued. Adding to that, many patients encountered serious 
complications like growth disorders, scoliosis, degenerative arthritis, and in 
long usage muscles can be atrophied. (6,40). 
  
 ii) Surgical management: 
 In conventional open surgery, the aim is to do total resection. This 
procedure leads to reducing the durability of bones. Sometimes, bones can be 
fractured too. So, additional surgical procedures such as bone grafting, 
internal fixation and postoperative immobilization may be required (6,41). 
 As per literature, Surgery gives 88% to 100% success rate. But, 4.5% to 
25% recurrence rates (6,41).  
Absolute indications for Surgical treatment are (3,41): 
1) Doubtful HPE of the lesion,  
2) Lesions occuring within 1–1.5 cm to the neurovascular structures, and  
3) Failed percutaneous ablation procedure not once. but, atleast twice. 
 Surgery leads to some practical problems like difficulty in intraoperative 
localization of the lesion, prolonged morbidity due to long stay in hospital and 
also takes long time for rehabilitation (3). 
  
 iii) Image guided percutaneous ablation: 
Techniques used are (6,41): 
1. Alcohol injection,  
2. Laser photocoagulation,  
3. Cryoablation, 
4. Microwave and Radiofrequency Ablation 
5. MR guided focused US therapy. 
 Alcohol ablation usually combined with minimally invasive CT guided 
[drill] resection. It is technically easier and cost effective method compared to 
other procedures. but, alcohol spreads to adjacent neurovascular bundles and 
tissues leads to failure and unnecessary complications (6,41,42). 
 MR Guided (MR compatible) Laser ablation and MR guided focused US 
therapy has success rate similar to the RFA, but not a cost effective one. Major 
setback is that, it does not allow the HPE confirmation and minor 
complications are comparatively higher than the RFA (6,41,43).   
 Another recent MR guided cryoablation which is a high cost method 
(1,6). Advantages are real time monitoring of changes happening during the 
process, provides better soft tissue contrast and no radiation. (6,44). 
  
RADIOFREQUENCY ABLATION: 
 Rosenthal et al., first described about minimally invasive procedure 
using RF in the year 1992(6,45). 
 It is comparatively newer modality for the treatment of osteoid 
osteoma with less morbidity and excellent cure rate (2). 
 Many traders are now circulating RFA devices for therapeutic purpose 
including: STAR med, RITA Medical System, Boston Scientific, Berchtold 
Medical Electronics, Tyco Healthcare and Radionics (2). 
 Success of RFA depends upon image guidance. CT leads 
MRI/USG/Fluoroscopy to treat bone lesions. Because, CT images are acquired 
faster with better bone resolution (1). 
Importance of image guidance at each step of the procedure: 
Pre-procedure:   
 1. To measure the lesion size, and to select appropriate active 
electrode tip with exact size (1). 
 2. To plan for easy and safer tract to reach the nidus, without 
disturbing neurovascular bundles (1). 
During procedure:  
 Constant monitoring of active electrode tip can be done (1). 
  
Post-procedure: 
 1. To minimize radiation dose, MRI is preferred over CT in post 
treatment follow-up (1,46).  
 2. To assess the procedure’s technical success. 
INSTRUMENTATION AND MECHANICS: 
 The RF device contains a RF generator which was connected with 
grounding pads and active electrode tip (1,47). The RITA device contains AC 
power generator with mobile electrode hub and multiple curved tips (2). 
 Radionics has a cooled tip probe with single needle and internal 
channel through which saline circulates. Thereby, helps for cooling it and also 
has numerous holes which permits saline leakage in order to increase tissue 
conductivity (1,2,46). 
 An artificial electrical circuit was made in patient by placing electrode 
tip in bone lesion and dispersing pads on thighs or back. The electric current 
from the RF generator flows via the electrode into the patient as 
radiofrequency waves/energy and goes out through the dispersing pads back 
to the generator(1)(figure 22). 
 
 
 
 
  
 
 
RF machine generates an alternating current of high RF waves which 
goes via the electrode tip into the lesion and transfers energy as heat which 
eventually causes cell death and coagulation necrosis (1).  
Heat is generated by impedance (resistive forces) that produce ionic 
and molecular coagulation(agitation) in the area(tissues) surrounding the 
electrode, while radio waves attempts to return to the ground pads (1). 
RF energy is transferred via the metal electrode (14 to 21 Gauge), and 
the entire electrode was insulated except at the tip, with an active tip length 
varying from 0.7 to 3 cm  (1). 
  
Figure 22: RF generator with its working principle (1). 
Different types of electrodes are available (1): 
1. Unipolar - with single electrode,  
2. Dipolar - with two electrodes,  
3. Cluster - with 3 or more closely spaced electrodes of 1 cm, and  
4. Umbrella type - expandable electrodes, with multiple electrode tines 
 (array like) that expands from a centrally placed cannula. 
Cooled tip probe is the one which is internally cooled by saline that 
flows into the lumen, but without having direct contact with tissue. Perfusion 
tip probe will have small apertures at the tip that allow fluids to be infused 
into the tissue (1). 
The variety of electrode and size of active tip chosen is vital in success 
of ablation. A single rod electrode is generally more appropriate in bone lesion 
treatment, because single electrode can be inserted via the drilled hole. Rod 
like monopolar electrodes distributes heat to surroundings in cylindrical way 
with rounded edge (1). 
Maximum heat is generated in tissues with least resistance, and cortical 
than marrow bone has higher tissue resistivity. So, cortical tissue offers higher 
resistant to heating. Thereby, has better insulating effect when intact, and 
protects adjacent soft tissues and cartilage (1,47). 
Dispersive grounding pads were applied on either side of patient’s 
thighs, in correct alignment with each other and with appropriate skin 
contact; both of them were kept at almost equal distance from the place of 
ablation and as nearest to the ablation site to allow the smallest current path 
via the patient (7) [Figure 23]. Right placement of these pads is a vital step in 
the procedure. 
 
 
 
 
Anaesthesia: 
Figure 23:  Schematic anteroposterior diagram showing right placement of 
dispersing pads (arrow)(7). 
In children mostly general anaesthesia was preferred over local 
anaesthesia (2). However, in lower extremities lesions spinal anaesthesia is 
preferred and local anesthesia was given for betterment of procedure. 
  
Lesion localization: 
The lesions were marked/targeted with the help of a MDCT scanner, 
with multiplanar evaluation to assess accurate needle position within the 
lesion (7). To minimize ionizing radiation exposure, KVP and MAS values were 
chosen as per ALARA (as low as reasonably achievable) principle (6).  
A grid can be kept over the patient’s skin in that particular area, before 
the first CT run to mark localization of a starting point (2). Markings on the 
grid can be visualised on the CT scan & helps to estimate distance across the 
skin (2). 
PROCEDURE:  
They used Single tip probe with exposed tip around 5 mm and that 
much is needed to ablate 1.5cm sized nidus. With the tip of the probe in 
correct position, the end of the cord plugged into the RF machine. The cord 
should be clamped to the patient to avoid any displacement while the CT table 
goes in and out of the scanner (2). 
It is necessary to add saline to the system to reduce impedance and 
favour ablation without over “burning” the lesional area (2). They kept RF 
machine settings at 90°C for 6 minutes. The RF machine will slowly elate the 
temperature, and timer gets started, when 90°C is reached (2,48). After 6 
minutes, the machine temperature will revert back to room temperature(2).  
  
Post procedure: 
The average time for patients to recover from anaesthesia was 2.3 
hours (7). Patients were advised to avoid sternous activities for 1 month, if 
they had lesions in lower limbs (7). 
Follow-up: 
 The mean follow-up period was 8 months (7) & mean time for 
complete disappearance of pain was 2 to 3 days (7) with first follow up MRI 
within 24 - 48 h after the procedure and next CT or MRI after 1 month and 1 
year. 
 
Complications: 
 Major: Any unexpected fracture or large skin burn which requires graft 
repair (7).  
 Minor: Transient paresthesia/erythema/small superficial skin burn 
surrounding the RF probe or grounding pad (7). 
  
 MATERIALS AND METHODS: 
 At our institution’s orthopaedic department, patients who presented 
with history of non-traumatic pain typically getting worse at night and relieved 
by taking aspirin with clinical diagnosis of osteoid osteoma are referred for 
radiological evaluation. The patients graded their pain at day and night on a 
visual analogue scale with grade 0 – no pain and grade 10 – unbearable pain.  
 Our study was accepted as ethical according to our institutional Ethical 
Committee, Govt. Kilpauk Medical College, Chennai -10, Protocol ID no: 
04/2015 dated 02.11.2015. 
Study design: 
 Prospective Interventional study. 
Study period: 
From November 2015 to September 2016. 
Study Population: 
Study included 16 patients with age group from 8 to 28 years (mean 
age - 16 years), which includes 14 male patients and 2 female patients. 
  
Criteria for diagnosis of osteoid osteoma: 
 Clinical criteria:  Patients Presenting with pain getting worse at night 
and relieved by taking aspirin with visual analog scale grade above 6. 
 Radiological criteria: Imaging wise documenting the radiolucent nidus 
less than 1.5cm with adjacent bony osteosclerosis and cortical 
thickening on thin slice CT (1 to 3 mm). 
INCLUSION CRITERIA: 
o Patients who met clinical and radiological criteria. 
EXCLUSION CRITERIA:               
o Patients who are symptomatically silent. 
o Patients whose primary was already known. 
o Patients with lesions close to neuro vascular bundles i.e within 2cm. 
o Non consenting and un co-operative patients. 
  
METHODOLOGY: 
All patients included in the study, were diagnosed as osteoid osteoma 
radiologically and posted for radiofrequency ablation. Day time & night time 
pain intensity of 16 patients was noted using visual analog scale. The 
procedure and its alternatives available are thorougly explained to the 
patients and their parents and informed written consent was obtained in all 
cases. 
  
 Before the procedure, Hemoglobin, clotting time, bleeding time, 
prothrombin time and INR were confirmed as normal. 
All patients underwent anaesthesia fitness assessment and planned 
under spinal anaesthesia. Prophylactic antibiotics were administered, prior to 
the procedure. Radiofrequency ablation machine and all anesthesia 
equipments are shifted to the room with the CT scanner. 
Radiofrequency ablation was done under Spinal anaesthesia (conscious 
sedation).  
Dispersive grounding pads were applied on either side of patient’s 
thighs, in correct alignment with each other and with appropriate skin 
contact; both of them were kept at almost equal distance from the place of 
ablation. 
 
  
 
 
 
 
 
 
The RFA equipment comprised an STAR med VIVA RF generator 
(Solutions for Thermo Ablation with RF medical technologies, South 
Korea),star RF cooled tip electrode with tip exposure 5 -10mm, 11 G COOK 
bone biopsy needle, a K-wire and a driller. 
Dispersive grounding pads were applied on either side of patient’s thighs. 
  
  
 Coolant Pump and container: 
STAR med  coolant container has Storage capacity around 3L with  two 
connectors for cool saline input and output. The tubes connects the coolant 
pump and the electrode. The temperature of coolant (saline)  kept below 
20℃.  
Lesion localization: 
The lesions were targeted with the help of a 16 slice MDCT scanner 
(Toshiba medical systems, Tokyo, Japan) with multi-planar evaluation to 
assess accurate needle position within the lesion.    
                  
                                  
 
 
 
 
 
  
RF generator with cooled tip RF probe & Coolant Pump – 1,2 &7. RF power 
supplied to electrode & targeted tissue, 3&4. Energy in calories 5. 
Impedance, 6. Actual amount of current via electrode, 8 &9. Time lap & 
Total ablation time,10. Temperature. 
PROCEDURE: 
1. Skin preparation and proper sterilization was done. 
2. Small skin incision was made using 11’ blade.  
3. 13-Guage bone biopsy needle was introduced into the lesion under CT 
guidance. And, in patients where there is marked perilesional sclerosis, 
the tumor was reached through a drill advanced over an appropriate 
Kirchner guidewire. Biopsy was taken and sent for HPE in formalin. 
4. Under aseptic precautions, a 350mm long, 15-gauge single cooled tip 
electrode with exposure tip of 5 -15mm length was then introduced 
into the centre of  osteoid osteoma nidus. 
5. The electrode was connected to the RF generator and coolant pump 
with cool saline. so, it reduces impedance and favour ablation without 
over “burning” the lesional area. 
6. RF machine settings changed to continuance mode and kept at 20 
watts for 6 minutes. The RF output is generated continuously with the 
setting value. 
7. The temperature shown in the generator won’t reflect the burning 
temperature. Because, we are ablating with cooled tip electrode 
connected to coolant pump.so, the observed electrode temperature 
will be less compared to actual burning temperature. 
8. Once procedure was over, a small compressive dressing was applied at 
the percutaneous puncture site.  
 
  
 
            
  
 
 
 
 
 
 
                   
       
Osteoid osteoma tibial diaphysis with thick sclerosis – Nidus was 
reached through K-wire using drill. 
Osteoid osteoma tibia diaphysis – RF probe introduced into nidus. 
  
 
 
 
 
 
 Post procedure: 
The average time for patients to recover from anaesthesia was 4 hours. 
Patients were advised to avoid sternous activities for 15 days. 
  
RF generator in continuance mode during ablation. 
  
Follow-up: 
Post procedure day and night time pain intensity was measured at 1 
week and 4 weeks using visual analog scale. Follow up CT/MRI taken at 4 
weeks. HPE reports were collected within a week. 
Criteria for assessment of success of the procedure: 
Technically success was considered, when the tip of the electrode was 
rightly placed into the nidus and the nidus was heated for the appropriate 
time, at correct parameters. 
Clinical success was considered, when patients gets complete relief 
from pain and getting back to normal activities. 
  
Case 1:  
A 17 year old male patient came with typical history of pain in left 
upper thigh, which is getting worsened at night. 
His pre-operative VAS was 6 in day and 9 in night time. Patient was 
subjected to thin slice CT. 
 
 
    
 
 
 
 
Plain axial CT left upper thigh reveals a well defined cortically placed 
radiolucent nidus with central calcification and surrounding minimal 
sclerosis in proximal femoral diaphysis. Nidus size was 7.5mm. 
Clinical and radiological criteria was met. So, Planned for RFA under 
spinal anaesthesia.  
 
 
 
The lesion was biopsied and sent for HPE and it confirmed the diagnosis 
as osteoid osteoma.  
 
 
 
During RF procedure with probe tip within the nidus 
Biopsy specimen with Hematoxylin and eosin staining showing  
irregular bony trabeculae with osteoblastic rimming( arrow) 
embedded in a hypo-cellular fibro-vascular stroma(*). 
 
Patient didn’t have any complications. His post op VAS at 1 week was 2 
in both day & night time and not had any pain at 4 weeks.Follow up imaging  
was done at 4 weeks and it showed no evidence of any residual/recurrent 
nidus. 
                            
 
 
 
 
 
 
 
 
Plain sagittal reformatted CT at 4 weeks shows the needle tract with no 
evidence of nidus. No residual sclerosis was noted. 
  
Case 2: 
A 14 year old male patient came with typical history of pain in left mid 
leg, which is getting worsened at night. 
His pre-operative VAS was 7 in day and 8 in night time. Patient was 
subjected to thin slice CT. 
                                  
   
 
 
 
 
    
 
 
 
 
Plain axial and coronal CT left leg reveals a well defined, cortically 
placed radiolucent nidus with central calcification and surrounding 
sclerosis in mid tibial diaphysis. Nidus size was 6.2 mm. 
  
Clinical and radiological criteria was met. So, Planned for RFA under 
spinal anaesthesia.  
                            
 
    The lesion was biopsied and sent for HPE and it came as sclerotic bone. 
                
During RF procedure with probe tip within the nidus 
  
Patient had mild skin burns, which got healed by its own. His post op 
VAS at 1 week was 1 in both day & night time and not had any pain at 4 
weeks. Follow up imaging  was done at 4 weeks and it showed no evidence of 
any residual/recurrent nidus. 
 
 
 
 
 
 
 
 
 
 
 
 
Plain radiograph leg Anteroposterior and lateral view at 4 weeks 
shows the needle tract with no evidence of nidus. Minimal residual 
sclerosis was noted. 
Biopsy specimen with Hematoxylin and eosin staining showing sclerotic 
bone. No evidence of osteoblasts. 
  
 
 
Case 3: 
A 17 year old female patient came with typical history of pain in left 
hip, which is getting worsened at night. 
Her pre operative VAS was 7 in day and 9 in night time. Patient was 
subjected to thin slice CT. 
 
                          
 
 
Plain axial CT left hip reveals a well defined , cortically placed radiolucent 
nidus with central calcification and surrounding minimal sclerosis in femoral 
neck(epiphysis). Nidus size was 6 mm. 
  
 
Clinical and radiological criteria was met. So, Planned for RFA under 
spinal anaesthesia.  
                    
 
The lesion was biopsied and sent for HPE and it came as sclerotic bone. 
During RF procedure with probe tip within the nidus 
                        
 
 
 
Patient didn’t have any complications. Her post op VAS at 1 week was 1 
in both day & night time and not had any pain at 4 weeks. Follow up imaging  
was done at 4 weeks and it showed no evidence of any residual/recurrent 
nidus. 
            
                            
 
 
 
 
Biopsy specimen with Hematoxylin and eosin staining showing sclerotic bone. 
No evidence of osteoblasts. 
  
  
Axial STIR and coronal T1 MR image at 4 weeks shows no evidence of nidus. 
No marrow edema was noted. 
Case 4: 
A 25 year old male patient came with typical history of pain in right mid 
leg, which is getting worsened at night. 
His pre operative VAS was 7 in day and 8 in night time. Patient was 
subjected to thin slice CT, radiograph and bone scintigraphy. 
 
 
 
 
 
 
 
 
Clinical and radiological criteria was met. So, Planned for RFA under 
spinal anaesthesia.  
 
Plain  AP radiograph, Axial CT and scintigraphy: right mid leg reveals a well 
defined , cortically placed radiolucent nidus with  no central calcification and 
surrounding sclerosis with double density sign (scintigraphy) in  mid tibial shaft 
Nidus size was 8mm. 
During RF procedure with probe tip within the nidus 
 The lesion was biopsied and sent for HPE and it confirmed the diagnosis 
as osteoid osteoma.  
 
 
 
Patient had mild skin burns, which got healed by its own. His post op 
VAS at 1 week was 5 in  day &  7 in night time and had persistence of pain at 4 
weeks. Follow up imaging  was done at 4 weeks and it showed  evidence of 
residual nidus. 
Biopsy specimen with Hematoxylin and eosin staining showing Immature 
trabeculae(arrow) enveloped by prominent osteoblasts / clasts. 
 
  
Planned for 2nd RFA under spinal anaesthesia. 
                              
 
Plain axial CT at 4 weeks shows the needle tract with evidence of  
residual nidus. 
During 2nd  RF procedure with probe tip within the nidus 
 
                                     
 
 
 
STATISTICAL ANALYSIS & RESULTS 
The collected data were analysed with IBM.SPSS statistics 
software 23.0 Version. 
To describe about the data descriptive statistics frequency 
analysis, percentage analysis were used for categorical variables and the 
mean & S.D were used for continuous variables.  
To find the significant difference between the bivariate samples in 
Paired groups (Pre & Post) Wilcoxon signed rank test was used.   
Plain sagittal reformatted CT at 4 weeks after 2nd RFA  shows the needle 
tract with no evidence of nidus. No residual sclerosis was noted. 
For the multivariate analysis in the repeated measures (Pre, 
Week1&Week4) the Friedman test was used. 
To find the significance in categorical data Chi-Square test was 
used. In all the above statistical tools the probability value .05 is 
considered as significant level.  
Age & Gender distribution of osteoid osteoma in tables and diagrams:                      
 
 
Female, 2
Male, 14
Gender
  
 
 
Distribution of osteoid osteoma according to the Site of Origin in bar 
diagram and frequency tables:                                                      
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Tibia, 5
fibula, 1
Femur, 10
Bone
 Comparison of pre procedure day & night VAS with post procedure day 
& night VAS at 1 week and 4 weeks: 
NPar Tests: 
Wilcoxon Signed Ranks Test: 
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Diaphyseal Epiphyseal
Lesions
a. Pre op VAS night < Pre op VAS day 
b. Pre op VAS night > Pre op VAS day 
c. Pre op VAS night = Pre op VAS day 
d. post op vas at 1 week Night < post op vas at 1 week day 
e. post op vas at 1 week Night > post op vas at 1 week day 
f. post op vas at 1 week Night = post op vas at 1 week day 
g. post op vas at 4 weeks night < post op vas at 4 weeks day 
h. post op vas at 4 weeks night > post op vas at 4 weeks day 
i. post op vas at 4 weeks night = post op vas at 4 weeks day 
  
In comparison, Pre-operative VAS values between daytime and night 
time,  the difference was statistically significant ( Z value = -3.624 and p value 
= < .05). 
NPar Tests: 
Friedman Test: 
                  
                                  
 
  
 
 
 
 
 
 
 
 
Multivariate analysis using friedman test, reveals stastically significant p 
values(< .05) between  Day Pre op VAS, Post op VAS at 1 week and at weeks. 
Similar values were obtained for night VAS multivariate analysis too. 
Assessing the difference between the bivariate samples in Paired 
groups (Pre & Post ): 
 All three paired comparisons in day time i.e Pre op VAS vs Post op VAS 
at 1 week, Pre op VAS vs Post op VAS at 4 weeks and Post op VAS at 1 week vs 
Post op VAS at 4 weeks were found to be stastically significant (P value < .05). 
 
 
 
 
  
All three paired comparisons in night time i.e  Pre op  VAS vs Post op 
VAS at 1 week, Pre op VAS vs Post op VAS at 4 weeks and Post op VAS at 1 
week vs Post op VAS at 4 weeks were found to be stastically significant (P 
value < .05). 
 
 
 
 
 
 Descriptives: 
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The median Pre op VAS day time was 7 and median pre op VAS 
night time was 9.  
    The median post op VAS day time at 1 week was 1 and median post op 
VAS night time at 1 week was 2. 
The median post op VAS day/night time at 4 weeks was 0. 
COMPLICATIONS: 
 
 
 
Mild skin burns, 3
Nil, 13
Complications
 No major complications was observed. Three patients had mild 
skin burns  of less than 10 mm in RF probe insertion site, which got 
healed without having any secondary infection. 
 
Histopathological examination: 
 
 
4 out of 16 patients HPE reports came as osteoid osteoma. Rest of 
the  patients reports came as sclerotic bone. 
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 Comparison between nidus size and histopathological report yield: 
Cross tabs: 
 
 
 
 
  
 
 
 
6 patients had nidus size more than or equal to 7 mm and 4 out of 
6 patients HPE turned positive for osteoid osteoma. Whereas, 10 
patients had nidus size less than 7mm and their HPE reports came as 
sclerotic bone. This was statistically significant with P value < .05 using 
fisher’s exact test. 
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 Follow up imaging at 4 weeks: 
 
 
At 4 weeks follow up imaging using either radiograph or CT/MRI, 
one patient had residual nidus of size 4mm. Patient underwent second 
RFA and his treatment completed successfully. 
 
94%
6%
Follow up imaging at 4 weeks
no nidus residual
DISCUSSION 
A study by Karagoz et al., in 2016 the mean age among 18 patients 
was 17.4 years. In our study, the mean age was 16 years and no 
significant difference obtained (6). 
In our study, the mean nidus size was 6.6mm, whereas in karagoz 
et al., study the mean   nidus size was 8.06 mm. 
In our study with 16 patients, most common bone involved was 
femur (n= 10), followed by tibia (n =5) and fibula(n=1). Commonest 
location in bone was cortical (n=13), subperiosteal (n =2)   and 
intramedullary (n= 1). Among all, four patients had lesions in epiphysis. 
These observations are similar to results of several studies. But, we 
haven’t lesions in less common sites like spine and upper extremities. 
A study by Jahanbakhsh et al., in 2011 showed similar results. In 
their study of 44 patients, most common bone involved was femur 
followed by tibia and phalanx. Commonest location in bone was cortical 
followed by intramedullary and then sub-periosteal (5). 
  Kransdorf et al., in 1991(14) and Papathanassiou et al., in 2008(15) 
observed that more than 50% osteoid osteomas occurs in femur or tibia. 
They also observed 67% of femoral lesions are either inter trochanteric 
or intra-capsular location. In our study 93% lesions were in femur or tibia 
and out of 10 femoral cases, only 40% were seen in 
intertrochanteric/intra capsular location. 
 The RF machine, we used was STAR med VIVA RF generator 
(Solutions for Thermo Ablation with RF medical technologies, South 
korea), STAR RF cooled tip electrode  with coolant pump. The advantage 
of this system was minimal tissue charring/ over cooking, due to usage 
of cooled tip probe connected to cooled saline. Although it also works 
based on impedance, the input we are giving here was Watts, not the 
temperature. The machine inherently designed in such a way, when 
temperature goes beyond 99℃  it automatically turns off, and prevents 
over cooking. 
A study by Dicaprio et al., in 2007(2) and Santiago et al., in 
2009(7), used RITA and Radionics RF machines with dry tip electrode 
with input given was temperature (90℃ for 6 minutes). It ablates nidus 
at higher temperature, So, adjacent tissues also burns in few occasions 
and it has higher chance for over cooking of nidus. 
As like our study, most of the studies (1,2) uses single rod 
electrode for ablation of osteoid osteoma. So, these rods can be easily 
introduced via drilled hole. Unipolar tip electrode cooks in cylindrical 
fashion with rounded border. 
In our study with 16 patients, pre treatment median VAS was 7 
and post treatment median VAS at one week was 1 for day time and pre 
treatment median VAS was 9 and post treatment median VAS at one 
week was 1 for night time. The VAS reduction for both day and night 
time was statistically significant. 
Several supportive studies  to our results includes De Palma et al., 
reported in their study with 20 patients, night time mean VAS as 8.5 pre 
and 0.5 after treatment and day time mean VAS as 5.95 pre and 0.9 after 
treatment (6,49). Karagoz E. et al., reported in their study with 18 
patients, night time median VAS as 9 pre and 0 after treatment and day 
time median VAS as 7 pre and 0 after treatment (6). 
Morassi et al., in 2014 evaluated 11 patients and they observed 
the significant reduction in visual analog score in pre and post procedure 
evaluation i.e from 8.6 to 0. And, our study too reveals significant 
reduction in visual analog score i.e from 8 to 1(52). 
In a study by Rehnitz et al., (50) which included 72 patients and 
another study by Cantwell et al., (53) showed no correlation between 
nidus size and VAS. Age, gender and nidus size not affected the clinical 
success in Rosenthal et al., study in 2003(38). Compared to all these 
studies our study, not shown any correlation between age, sex, nidus 
size with VAS score or Clinical outcome. 
Patients getting complete relief from pain following treatment 
ranges between 1 day to 2 weeks. A study by Vanderschueren et al., in 
2002 which included 54 patients reveals 87% patients got completely 
relieved from pain on day 1. Whereas,13% patients recovered at two 
weeks (54). Another study in 2001 by Lindner et al., reported that 
complete relief of pain was obtained at the end of 1 week (55). 
Whereas, Karagoz et al., (6) reported between 3 to 10 days. In our study 
sparing, one patient with residual lesion, rest all relieved from pain in 
between 8 to 9 days. 
In our study with 16 patients, 15 out of 16 patients got primary 
technical and clinical success i.e 93.8% and second time RF had 100% 
technical and clinical success. The problem we encountered in that one 
case was high impedance probably, because of large size drill compared 
to electrode size. So, technically not able to achieve adequate ablation, 
that was needed to cook the nidus (7).  
However, the success rates of our study was comparable with 
several other studies like Cantwell CP et al., in 2004 and Yang et al., in 
2007 observed technical success, near 100% and clinical success of 76 to 
100% and after second Radio Frequency ablation the success rate was 
near 100%(41,56). 
A study by Rehintz et al., in 2013 which included 72 patients 
showed 99% primary clinical success rate and 100% secondary success 
rate (50). Another similar results i.e 100% technical success, 94% Primary 
success and 100%   secondary success rate was obtained in study by 
Karagoz et al., in 2016(6). 
Jankharia et al., study in 2009 which included 40 Patients, showed 
100% technical success with 2 patients had recurrence at 5th and 8th 
month. So, the primary success rate was around 95% and after 2nd RFA 
the success rate was 100% (7).  
In 2009, A study by Fernando et al., out of 15 patients 14 patients 
(93%) had clinical success rate. However, one patient with tibial osteoid 
osteoma had recurrence and the nidus was removed via open surgery 
(1). 
In our study, we had 3 patients with mild skin burns with no major 
complications. All three had lesions in mid tibial shaft and distance 
between lesions and skin was less than 1 cm.so, the skin burns might 
have occurred due to some transient contact between electrode tip and 
skin while ablating.  However, all three skin burns healed after topical 
application. None of the patients, had any other complications. 
A study by Jankharia et al., in 2009(7) Out of 40 patients, one 
patient had skin burn of around 6mm near probe insertion site in mid 
arm i.e diaphysis of humerus and the nidus was 1.7cm away from skin 
surface. They also experienced one more complication, a small bony chip 
fracture occurred in entry site. Since, it is a sclerotic bone it can be 
negligible and patient was advised for few weeks of rest. 
Goetz et al., in 2004(10) and Callstrom et al., in 2006(48) observed 
certain complications like damage to neurovascular bundles, 
pathological fractures, muscle and skin burns turning into abscess in 
entry path. They also stated about burns occurring near grounding pads 
site. 
Another observation was made by Tins et al., (57) in 2006, while 
ablating intra articular osteoid osteomas in weight bearing joints: lower 
extremities, their occurred damage to cartilage which in turn leads to 
some disability. They also added that few of the patients experienced 
mechanical weakening of bone. 
Motamedi D et al. in 2009(51) and Vanderschueren et al., in 
2002(54) said superficial thermo-coagulation sometimes lead into skin 
burns. 
Rosenthal et al., in 2003(38) and Lindner et al., in 2001(55) 
observed in their study, Radio Frequency Ablation complications like 
neural injury occurs when the lesions stay closer to nerves i.e within 1 
cm, particularly while ablating spinal and hand osteoid osteomas. 
Gangi et al., in 2007(58) stated that osteoid osteomas located 
within 8mm from skin surface should be treated with other modality 
rather than percutaneous Radio Frequency Ablation due to its 
complications like skin burns and tissue necrosis. 
In our study, we found that the lesions with nidus size less than 
7mm (10 patients) HPE reveals only sclerotic bone. Whereas, if nidus size 
exceeds 7mm (4 out of 6 patients) then, HPE came as osteoid osteoma 
with possible explanation that the smaller nidus might have been 
destroyed while drilling itself.  
  
 LIMITATIONS OF THE STUDY 
 Smaller sample size. 
 
 We haven’t done, RFA in other less common sites of osteoid 
osteoma like spine, ribs, hands and feet. So, the Success rate in 
those sites was not assessed.   
 
 Average follow up period in our study was, only 2 to 3 months 
which was not adequate. Because, most of the recurrences occur 
in between 3 to 6 only (45). 
  
  
CONCLUSION 
i. Radio Frequency Ablation is a safe, quick, minimally invasive 
and extremely effective method in osteoid osteoma 
management. 
 
ii. We have been able to achieve a high technical and clinical 
success rate, with less morbidity & complications. 
 
iii. Computed Tomography Guided Radio Frequency Ablation 
should be the method of choice for treating osteoid osteomas. 
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ABBREVIATIONS 
 
RFA   –  RadioFrequency Ablation 
CT   –  Computed Tomography 
MRI   –  Magnetic Resonance Imaging 
US  - UltraSound 
MDCT  – Multi Detector Computed Tomography 
T1WI  – T1 Weighted Imaging 
T2WI  – T2 Weighted Imaging 
STIR   – Short Tau Inversion Recovery  
CECT  – Contrast Enhanced Computed Tomography 
FDG PET  – FluoroDeoxyGlucose Positron Emission Tomography 
AP   – Antero Posterior 
RF  - Radio Frequency 
COX   – Cyclo Oxygenase 
PGE2   – ProstaGlandin E2 
NSAID’S  – Non Steroidal Anti Inflammatory Drugs 
HPE   – HistoPathological Examination 
KVP   –  KiloVoltage Peak 
MAS   – Milliampere Seconds 
VAS   – Visual Analog Scale 
K wire  – Kirschner wire 
G   – Gauge 
STAR med  – Solution for Tomo Ablation with RF Medical  
   technologies 
VIVA  – Variable Insulation Vari-sized Ablation 
RITA  – RF Interstitial Tissue Ablation 
  
PATIENT INFORMATION SHEET 
Investigator : 
Name of Participant: 
Title: Image guided RadioFrequency Ablation of Bone Tumours 
You (your son/daughter) are invited to take part in this research/ study 
/procedures. The information in this document is meant to help you 
decide whether or not to take part. Please feel free to ask if you have any 
queries or concerns. 
You(your son/daughter)are being asked to participate in this study being 
conducted in Govt. Kilpauk Medical College & Hospital. 
Osteoid osteoma is a extremely painful benign bone lesion typically 
smaller than 1.5cm, with pain getting worsened in night and relieved by 
salicylates which has predilection for young boys. Image guided 
radiofrequency ablation is the current treatment modality of choice in 
treating osteoid osteoma with 95 to 100% cure rate 
Our study is focused in evaluating the technical and therapeutic efficacy 
of radiofrequency ablation in osteoid osteoma in our  hospital, to assess 
the technical limitations and post procedural complications. 
Study Procedures 
 First you will be subjected to imaging using Multi Detector CT in which 
your lesion site will be imaged.A series of planning images are 
performed, with the lesion to be ablated planned on the computer terminal 
and then marked on your skin.Spinal anaesthesia will be given. Then, 
skin preparation will be done. Using driller right path to lesion will be 
created. Followed by a biopsy from lesion then, Radio Frequency 
generator will be turned on and connected with coolant and RF electrode. 
Under CT guidance the lesion will be ablated. The whole procedure will 
take around 90 minutes The specimen obtained is sent for 
histopathological examination. 
After 24 hours rest ,you can limit your activities for  2 weeks.You may 
have to come to the hospital (study site) for examination and 
investigations apart from your scheduled visits, if required. 
Women of Childbearing Potential 
You must not participate if you are pregnant, breast feeding a child, or if 
you are of child bearing potential and not practicing two forms of 
effective methods of contraception. 
Possible Risks to you(your son/daughter): 
Risks of this procedure is rare and includes     
Skin burns:most of these are minor.However, it rarely needs antibiotic 
support and wound closure. 
Bleeding:  this is also rare and common in patients with bleeding 
disorders. 
Nerve damage: When lesions lie close to neuro vascular bundles. 
Possible benefits to other people 
The result of the research may provide benefits to the society in terms of 
advancement of medical knowledge and/or therapeutic benefits to future 
patients 
Confidentiality of the information obtained from you (your son/daughter) 
You(your son/daughter) have the right to confidentiality regarding the 
privacy of your(your son/daughter)medical information (personal details, 
results of physical examinations, investigations, and your medical 
history). By signing this document, you(your son/daughter) will be 
allowing the research team investigators, other study personnel, sponsors, 
IEC and any person or agency required by law like the Drug Controller 
General of India to view your data, if required. 
The information from this study, if published in scientific journals or 
presented at scientific meetings, will not reveal your(your 
son/daughter)identity. 
How will your decision to not participate in the study affect you(your 
son/daughter)? 
Your decisions to not participate in this research study will not affect 
your(your son/daughter)medical care or your relationship with 
investigator or the institution.  
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the 
right to withdraw from this study at any time during course of the study 
without giving any reasons. 
However, it advisable that you talk to the research team prior to stopping 
the treatment. 
  
PROFORMA 
STUDY TITLE: 
“IMAGE GUIDED RADIOFREQUENCY ABLATION OF 
BONE TUMOURS” 
S.No: 
Name : 
Age/Sex : 
Address  with Contact No: 
 
Presenting Complaints and History: 
 
Imaging: site(transverse & longitudinal location, bone involved, nidus 
size) 
Complications: 
HPE: 
Follow up imaging at 4 weeks: ( nidus seen or not) 
VAS 
 
 
 
Pre op  Post op at 1 week Post op at 4 weeks 
Day Night Day Night Day Night 
Grade       
 
Signature of Investigator                 Signature of the Participant            
 Witness:   
PATIENT  INFORMED  CONSENT  FORM 
Title of the study: “Image guided radiofrequency ablation of bone 
tumours”.  
Name of the Participant:                                                                                                            
Name of the Principal (Co-Investigator):                                                                         
.Name of the Institution:                                                                                                           
Age/sex:  
Documentation of the informed consent: 
I have read the information in this form (or it has been read to me). I was 
free to ask any questions and they have been answered. I am over 18 
years of age (Father/Mother in case of age less than 18 years) and, 
exercising  my free  power of  choice, hereby give  my consent   to   be  
included (to include my son/ daughter) as  a  participant. 
1.   I have read and understood this consent form and the information 
provided to me. 
2.   I have had the consent document explained to me. 
3.   I have been explained about the nature of the study. 
4.   I have been explained about my rights and responsibilities by the 
investigator. 
5.   I have been advised about the risks associated with my(my 
son/daughter) participation in this study.* 
7.   I agree to cooperate with the investigator and I will inform him/her 
immediately if I (my son/daughter)suffer unusual symptoms. * 
8.   I have(my son/daughter) not participated in any research study within 
the past month(s). * 
9.   I am aware of the fact that I(my son/daughter) can opt out of the study 
at any time without having to give any reason and this will not affect my 
(son/daughter) future treatment in this hospital. * 
11. I am also aware that the investigator may terminate 
my(son/daughter)participation in the study at any time, for any reason, 
without my consent. * 
12. I hereby give permission to the investigators to release the 
information obtained from me(my son/daughter) as result of participation 
in this study to the sponsors, regulatory authorities, Govt. agencies, and 
IEC. 
13. I have understand that  my( son/daughter)  identity will be kept 
confidential if my data are publicly presented 
14. I have had my questions answered to my satisfaction. 
15. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact 
the investigator. By signing this consent form I attest that the information 
given in this document has been clearly explained to me and understood 
by me, I will be given a copy of this consent document. 
For adult participants: 
Name and signature / thumb impression of the participant: 
Name                                                  Signature 
Date  
Name and Signature/thumb impression of the participant’s Parent: 
Name                                                  Signature 
Date  
Name and Signature of the investigator or his representative obtaining 
consent: 
Name                                                  Signature 
Date  
 
  
 
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
